LN制药集团分销渠道的管理研究
[Abstract]:With the improvement of people's living standard and the increasing demand for medical care, the demand for medicine is increasing. There are some problems in the distribution of drugs in China. At the same time, the distribution channels of drugs are changing with the change of social environment. In the new social environment, LN Pharmaceutical Group has a clear understanding of the strengths, weaknesses, opportunities and challenges faced by the enterprise, how to achieve a new sales breakthrough in practice to enhance the market share of the enterprise. Finally, to realize the take-off of national enterprises. Based on the theory of distribution channel and the analysis of related documents, this paper firstly analyzes the current situation of the distribution of pharmaceutical industry in China, finds out the existing problems, and summarizes the existing channels of drug distribution. To study the advantages and disadvantages of various distribution channels; Secondly, by visiting LN Pharmaceutical Group, comparative analysis, using the SWOT method to study the strengths, weaknesses, opportunities and challenges of the group; Finally, the deep distribution model is introduced to bring distribution opportunities for LN pharmaceutical group, while the existing distribution channels are improved in the areas without deep distribution, and some suggestions for improvement of distribution channels are put forward. This article is divided into five parts: the first chapter, introduction. This part mainly introduces the background of this paper, the basic content of this paper and the technical route, as well as the purpose and significance of this paper. The second chapter is a review of relevant theories. Citing the relevant theories of distribution channels, the research methods of this paper and the theoretical research results of domestic and foreign scholars on the management of distribution channels, summarizing the theoretical knowledge involved in distribution channels and the previous studies of scholars, the theoretical basis of the subsequent research in this paper is analyzed. Do a reasonable and well-founded LN pharmaceutical group distribution channel research. The third chapter, the medicine profession management and the channel pattern analysis. This paper analyzes the management characteristics of the pharmaceutical industry in China and the problems existing in the management of the drug distribution channels in China, and probes into the main models of the current research on the drug distribution channels. Through the investigation of the unit members and dealers of LN Pharmaceutical Group, the distribution channel of LN Pharmaceutical Group was analyzed by SWOT. The fourth chapter, distribution model design and distribution channel management. On the basis of studying the theory of deep distribution model, this paper analyzes the problems existing in the deep distribution of LN pharmaceutical group, and then designs the deep distribution model and implementation process of LN pharmaceutical group. This paper discusses some suggestions for improving the distribution channel management of LN Pharmaceutical Group. Chapter five, conclusion and prospect.
【学位授予单位】:南京农业大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:F274;F426.72
【相似文献】
相关期刊论文 前10条
1 ;国家天然药物工程技术研究中心已在成都地奥制药集团有限公司挂牌运行[J];天然产物研究与开发;2001年05期
2 ;国家天然药物工程技术研究中心已在成都地奥制药集团有限公司挂牌运行[J];天然产物研究与开发;2001年06期
3 ;做百年药业,还原于社会——奋进中的武汉远大制药集团有限公司[J];中国医院药学杂志;2005年11期
4 ;德国、法国制药集团联合来沪访问[J];中成药;1997年01期
5 李永佑;东北制药集团是怎样创造奇迹的?[J];政策与管理;2000年08期
6 周敏,马艳霜;昆明制药集团及其药品包装[J];印刷世界;2004年12期
7 ;东北制药集团撤出沈阳红药将专攻化学药[J];化工中间体;2008年09期
8 李德弟;张利岩;;责任和良心的统一——记曲风采总经理和吉林吉春制药集团有限公司[J];经济视角;2010年01期
9 江中银;;金陵制药集团腾飞的“脉络”[J];改革与开放;1998年10期
10 ;平光制药集团简介[J];医学研究生学报;2013年09期
相关会议论文 前1条
1 ;武汉远大制药集团产品介绍[A];江西省第九次中西医结合眼科、中医眼科学术交流会论文汇编[C];2008年
相关重要报纸文章 前10条
1 ;东北制药集团公司——国企改革脱困的一面旗帜[N];人民政协报;2000年
2 郭雄伟;陕西盘龙制药集团公司举行十周年庆典活动[N];商洛日报;2008年
3 黄勇;云南特安呐制药集团打好“三七牌”[N];云南经济日报;2007年
4 本报记者 马建忠;东方巨龙擦亮眼[N];医药经济报;2009年
5 记者 李敬元;石家庄制药集团来我市考察洽谈合作项目[N];四平日报;2007年
6 采田;青霉素粉针剂市场分析[N];医药经济报;2001年
7 记者 尤勇;东北制药集团入驻药都企业日前开工建设[N];本溪日报;2011年
8 记者 范妤;全力支持企业做强做大[N];泸州日报;2011年
9 曹勇;制剂研究:药物的再开发[N];中国医药报;2002年
10 通讯员 张洁 王俭峰 记者 赵莹;东北制药集团战略转型初具规模[N];中国医药报;2009年
相关硕士学位论文 前6条
1 李鹏飞;丰业制药集团股权证券化案例研究[D];大连理工大学;2007年
2 王蕊;H制药集团技术人员激励案例研究[D];大连理工大学;2015年
3 柴雪青;项目质量管理在东北制药集团新区建设项目中的应用[D];吉林大学;2012年
4 王伟;LN制药集团分销渠道的管理研究[D];南京农业大学;2014年
5 黄伟伟;江中制药集团发展战略研究[D];南昌大学;2010年
6 姚浩文;天士力制药集团股份有限公司投资价值分析[D];昆明理工大学;2015年
,本文编号:2364875
本文链接:https://www.wllwen.com/jingjilunwen/gongyejingjilunwen/2364875.html